Clinical Trials Related to Geographic Atrophy

Related studies linked through entity extraction aliases.

A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251

Status: RECRUITING
Phase: PHASE2

Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy

Status: COMPLETED
Phase: PHASE3

Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD

Status: RECRUITING
Phase: NA

Oral Postbiotics in Patients With Macular Atrophy

Status: UNKNOWN
Phase: NA

Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1/PHASE2

A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Status: TERMINATED
Phase: PHASE2

ONL1204 Ophthalmic Solution in Patients With Geographic Atrophy Associated With Age-related Macular Degeneration

Status: COMPLETED
Phase: PHASE1

Project AMD: Comprehensive Characterisation of Age-Related Macular Degeneration and Its Progression

Status: RECRUITING
Phase: N/A

Restoration of Central Vision With the PRIMA System in Patients With Atrophic AMD

Status: ACTIVE_NOT_RECRUITING
Phase: NA

A Study Investigating the Efficacy and Safety of Intravitreal Injections of ANX007 in Patients With Geographic Atrophy

Status: COMPLETED
Phase: PHASE2

A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Dry Age-related Macular Degeneration

Status: TERMINATED
Phase: PHASE2

A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7303359 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

Status: COMPLETED
Phase: PHASE1

A Study Assessing the Long-Term Safety and Tolerability of Galegenimab (FHTR2163) in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Status: TERMINATED
Phase: PHASE2

A Study of NGM621 in Participants With Geographic Atrophy

Status: COMPLETED
Phase: PHASE2

A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor)

Status: COMPLETED
Phase: PHASE3

Intravitreal AAVCAGsCD59 for Advanced Dry Age-related Macular Degeneration (AMD) With Geographic Atrophy (GA)

Status: WITHDRAWN
Phase: PHASE2

Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration

Status: RECRUITING
Phase: PHASE1/PHASE2

First in Human Study to Evaluate the Safety and Tolerability of GEM103 in Geographic Atrophy Secondary to Dry Age Related Macular Degeneration

Status: COMPLETED
Phase: PHASE1

Study of NGM621 in Participants With Geographic Atrophy

Status: COMPLETED
Phase: PHASE1

A Study Assessing the Safety, Tolerability, and Efficacy of Galegenimab (FHTR2163) in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)

Status: TERMINATED
Phase: PHASE2